| Literature DB >> 23724228 |
Guicheng Zhang1, Catherine M Hayden, Jack Goldblatt, Patrick Holt, Peter N Le Souëf.
Abstract
The expression of allergic phenotypes involves complex inter-relationships among several Th2 and Th1 cytokines as well as the regulator cytokine interleukin (IL)-10. These direct or indirect interrelationships may distort the true associations of cytokine responses with these phenotypes. In this study, we aimed to clarify the effects of the regulatory cytokine IL-10 and Th1 cytokine interferon-gamma (IFN-γ) on allergic phenotypes after adjusting for the correlations with Th2 cytokines. After adjusting for Th2 cytokines, IL-10 and IFN-γ were protective against atopy. Adjusted levels of IL-10 and IFN-γ stimulated with house-dust mite (HDM) were significantly lower in atopics than non-atopics, for IL-10 adjusting for IL-5 (P = 0.002), IL-13 (P = 0.012), IL-9 (P = 0.016), and IL-4 (P = 0.043), and for IFN-γ adjusting for IL-5 (P = 0.005), IL-13 (P = 0.005), and IL-9 (P = 0.037). IL-10 and IFN-γ levels stimulated with phytohaemagglutinin (PHA) and staphylococcal enterotoxin B (SEB) exhibited a similar pattern. The adjusted levels of IL-10 and IFN-γ stimulated with HDM, PHA or SEB were all significantly negatively correlated with total serum IgE, except for IFN-γ stimulated with SEB. Levels of Th2 cytokines distort the associations of IL-10 and IFN-γ with allergic phenotypes. Removing the covariance with Th2 cytokines, both IL-10 and IFN-γ were protective against atopy.Entities:
Year: 2011 PMID: 23724228 PMCID: PMC3658504 DOI: 10.5402/2011/405813
Source DB: PubMed Journal: ISRN Allergy ISSN: 2090-553X
Correlation coefficients between cytokines stimulated by HDM.
| IL-10 | IFN- | IL-5 | IL-13 | IL-9 | IL-4 | |
|---|---|---|---|---|---|---|
| IL-10 | 1 | |||||
| IFN- | 0.615** | 1 | ||||
| IL-5 | 0.321** | 0.268** | 1 | |||
| IL-13 | 0.453** | 0.543** | 0.746** | 1 | ||
| IL-9 | 0.340** | 0.360** | 0.694** | 0.762** | 1 | |
| IL-4 | 0.141 | 0.124 | 0.505** | 0.479** | 0.593** | 1 |
**P < 0.01.
Correlation coefficients between cytokines stimulated by PHA or SEB.
| PHA | SEB | |||||||
|---|---|---|---|---|---|---|---|---|
| IL-10 | IFN- | IL-5 | IL-13 | IL-10 | IFN- | IL-5 | IL-13 | |
| IL-10 | 1 | 1 | ||||||
| IFN- | 0.726** | 1 | 0.553** | 1 | ||||
| IL-5 | 0.558** | 0.567** | 1 | 0.400** | 0.102 | 1 | ||
| IL-13 | 0.407** | 0.415** | 0.652** | 1 | 0.424** | 0.130 | 0.623** | 1 |
**P < 0.01.
Raw and adjusted IL-10 and IFN-r levels (log value) stimulated with HDM in children with and without atopy.
| Atopy ( | Nonatopy ( |
| |||||
|---|---|---|---|---|---|---|---|
| Mean | 95% CI | Mean | 95% CI | ||||
| Lower | Upper | Lower | Upper | ||||
| IL-10 (HDM) | |||||||
| No adjustment | 2.33 | 2.10 | 2.56 | 2.62 | 2.33 | 2.91 | 0.11 |
| By IL-5 | 2.22 | 2.02 | 2.42 | 2.75 | 2.47 | 3.03 |
|
| By IL-13 | 2.28 | 2.09 | 2.47 | 2.68 | 2.42 | 2.95 |
|
| By IL-9 | 2.27 | 2.06 | 2.48 | 2.70 | 2.41 | 2.99 |
|
| By IL-4 | 2.29 | 2.07 | 2.52 | 2.67 | 2.37 | 2.97 |
|
|
| |||||||
| IFN-r (HDM) | |||||||
| No adjustment | 2.48 | 2.15 | 2.80 | 2.93 | 2.45 | 3.40 | 0.113 |
| By IL-5 | 2.34 | 2.04 | 2.64 | 3.09 | 2.64 | 3.54 |
|
| By IL-13 | 2.38 | 2.11 | 2.66 | 3.04 | 2.66 | 3.42 |
|
| By IL-9 | 2.43 | 2.12 | 2.74 | 3.00 | 2.53 | 3.47 |
|
| By IL-4 | 2.46 | 2.12 | 2.80 | 2.96 | 2.46 | 3.45 | 0.091 |
Raw and adjusted IL-10 and IFN-r levels (log value) stimulated with either PHA or SEB in children with and without atopy.
| Atopy ( | Nonatopy ( |
| |||||
|---|---|---|---|---|---|---|---|
| Mean | 95% CI | Mean | 95% CI | ||||
| Lower | Upper | Lower | Upper | ||||
| IL-10 (PHA) | |||||||
|
|
| ||||||
| No adjustment | 4.67 | 4.45 | 4.88 | 4.99 | 4.79 | 5.19 |
|
| By IL-5 | 4.63 | 4.47 | 4.80 | 5.03 | 4.86 | 5.20 |
|
| By IL-13 | 4.64 | 4.45 | 4.82 | 5.03 | 4.83 | 5.22 |
|
| IL-10 (SEB) |
|
| |||||
| No adjustment | 5.47 | 5.31 | 5.62 | 5.70 | 5.51 | 5.89 | 0.062 |
| By IL-5 | 5.43 | 5.29 | 5.57 | 5.75 | 5.58 | 5.92 |
|
| By IL-13 | 5.45 | 5.32 | 5.59 | 5.72 | 5.54 | 5.89 |
|
|
| |||||||
| IFN-r (PHA) | |||||||
|
|
| ||||||
| No adjustment | 6.11 | 5.84 | 6.38 | 6.50 | 6.29 | 6.71 |
|
| By IL-5 | 6.07 | 5.87 | 6.28 | 6.55 | 6.37 | 6.74 |
|
| By IL-13 | 6.08 | 5.85 | 6.31 | 6.54 | 6.34 | 6.75 |
|
| IFN-r (SEB) |
|
| |||||
| No adjustment | 10.01 | 9.84 | 10.17 | 10.09 | 9.91 | 10.27 | 0.50 |
| By IL-5 | 10.00 | 9.83 | 10.16 | 10.10 | 9.92 | 10.28 | 0.39 |
| By IL-13 | 10.00 | 9.83 | 10.17 | 10.10 | 9.92 | 10.27 | 0.44 |
Correlation coefficients between raw or adjusted IL-10 and IFN-γ and total IgE.
| Stimulated with | ||||||
|---|---|---|---|---|---|---|
| HDM | PHA | SEB | ||||
| Coeff. |
| Coeff. |
| Coeff. |
| |
| IL-10 | ||||||
| Raw | −0.114 | 0.20 | −0.070 | 0.43 | −0.084 | 0.35 |
| By IL-5 | −0.244 |
| −0.260 |
| −0.233 |
|
| By IL-13 | −0.214 |
| −0.17 |
| −0.190 |
|
| By IL-9 | −0.184 |
| ||||
| By IL-4 | −0.142 | 0.12 | ||||
| IFN- | ||||||
| Raw | −0.143 | 0.11 | −0.085 | 0.34 | −0.091 | 0.31 |
| By IL-5 | −0.249 |
| −0.285 |
| −0.125 | 0.16 |
| By IL-13 | −0.279 |
| −0.190 |
| −0.119 | 0.18 |
| By IL-9 | −0.189 |
| ||||
| By IL-4 | −0.140 | 0.13 | ||||
Odds ratios of IL-10 and IFN-γ for atopy estimated by two adjusted methods*.
| Method one | Method two | |||||||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |||
| Lower | Upper | Lower | Upper | |||||
| IL-10 stimulated with HDM (HDM) | ||||||||
| Raw | .762 | .544 | 1.066 | 0.11 | ||||
| By IL-5 | .481 | .307 | .755 |
| .567 | .390 | .825 |
|
| By IL-13 | .602 | .402 | .902 |
| .614 | .415 | .909 |
|
| By IL-9 | .628 | .427 | .924 |
| .631 | .430 | .926 |
|
| By IL-4 | .693 | .484 | .992 |
| .693 | .485 | .992 |
|
| IL-10 (PHA) | ||||||||
| Raw | .615 | .392 | .963 |
| ||||
| By IL-5 | .401 | .226 | .712 |
| .403 | .227 | .715 |
|
| By IL-13 | .472 | .278 | .802 |
| .489 | .293 | .817 |
|
| IL-10 (SEB) | ||||||||
| Raw | .607 | .357 | 1.031 | 0.065 | ||||
| By IL-5 | .416 | .224 | .770 |
| .427 | .232 | .784 |
|
| By IL-13 | .480 | .259 | .890 |
| .489 | .267 | .894 |
|
| IFN- | ||||||||
| Raw | .838 | .673 | 1.043 | 0.114 | ||||
| By IL-5 | .635 | .473 | .853 |
| .720 | .567 | .914 |
|
| By IL-13 | .670 | .503 | .893 |
| .681 | .515 | .900 |
|
| By IL-9 | .769 | .599 | .987 |
| .772 | .603 | .988 |
|
| By IL-4 | .822 | .655 | 1.033 | 0.092 | .822 | .655 | 1.033 | 0.093 |
| IFN- | ||||||||
| Raw | .645 | .433 | .963 |
| ||||
| By IL-5 | .437 | .260 | .734 |
| .433 | .256 | .732 |
|
| By IL-13 | .502 | .311 | .812 |
| .517 | .323 | .827 |
|
| IFN- | ||||||||
| Raw | .836 | .500 | 1.399 | 0.50 | ||||
| By IL-5 | .788 | .467 | 1.330 | 0.37 | .794 | .472 | 1.337 | 0.39 |
| By IL-13 | .815 | .485 | 1.368 | 0.44 | .815 | .484 | 1.370 | 0.44 |
*Method one: “Raw” model only includes one independent variable: either raw IL-10 or IFN-γ; “by IL-5” includes either raw IL-10 or IFN-γ and IL-5; “by IL-13” includes either raw IL-10 or IFN-γ and IL-13; “by IL-9” includes either raw IL-10 or IFN-γ and IL-9; “by IL-4” includes either raw IL-10 or IFN-γ and IL-4. Method two: either adjusted IL-10 or IFN-γ was fitted in the logistic regression model.; “by IL-5”, “by IL-13”, “by IL-9”, and “by IL-4”indicate that the levels of either adjusted IL-10 or IFN-γ was adjusted by IL-5, IL-13, IL-9, and IL-4, respectively.
Figure 1Illustrations of the major finding in the present study for IL-10.